Interesting. Basically the 'morning after pill' for Covid, taken within five day of symptoms presenting. There will also be substantial in practice evidence from the States before we see this in Canada.
Quote:
|
Merck and its partner Ridgeback Biotherapeutics announced Friday that early results from its trials show that patients who received molnupiravir within five days of COVID-19 symptoms had about half the rate of hospitalization and death as those who received a placebo.
|
Quote:
|
Sharma said Health Canada has no specific time for completion of the review as it can take "months," but also that the pill will be evaluated and "held to the standards" as any other medication or treatment.
|
Quote:
Merck said it plans to submit the data in the coming days to health officials in the U.S. and other countries to authorize the pill's use.
A decision from the U.S. Food and Drug Administration could come within weeks after that, and be distributed soon after.
|
https://www.ctvnews.ca/health/corona...ment-1.5607843